Metabolome screening of CD4+t cell subsets in a pre-clinical model of cgvhd 30 samples
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00313
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,750
Award facts
- Contract value 100% obligated
- $9,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Morrisville, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $9,750 | |
| Original award | $0 |
About this award
The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $9,750.00 for metabolome screening of CD4+T cell subsets in a pre-clinical model of chronic graft-versus-host disease across 30 samples. The order was issued on April 18, 2018, with an ultimate completion date of April 22, 2018. Performance takes place in Morrisville, North Carolina. The contract is firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract 75N91018P00313?
75N91018P00313 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on April 18, 2018.
How much is contract 75N91018P00313 worth?
The government has obligated $9,750 on 75N91018P00313.
Was contract 75N91018P00313 competed?
The extent of competition for 75N91018P00313 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award